Legislation Details

File #: 26-0487    Version: 1 Name:
Type: Financial Authorization Status: Passed
File created: 1/9/2026 In control: Commissioners Court
On agenda: 1/29/2026 Final action: 1/29/2026
Title: Request for approval of a public health or safety exemption from the competitive bid requirements with Morris & Dickson Co., LLC in the amount of $350,000 for 340B Pharmaceuticals for Public Health Services for the period of January 29, 2026 - January 28, 2027.
Primary Department: Purchasing
Primary Department Head/Elected Official: Kimberly J. Williams, JD

Secondary Department: Public Health Services
Secondary Department Head/Elected Official: Leah Barton

Regular or Supplemental RCA: Regular RCA

Type of Request: Financial Authorization

Project ID (if applicable): N/A
Vendor/Entity Legal Name (if applicable): Morris & Dickson Co., LLC

MWBE Contracted Goal (if applicable): N/A
MWBE Current Participation (if applicable): N/A
Justification for 0% MWBE Participation Goal: N/A - Goal not applicable to request

Grant Indirect Costs Rate (if applicable):
Justification for 0% Grant Indirect Costs Rate (if applicable): Choose an item.

Request Summary (Agenda Caption):
title
Request for approval of a public health or safety exemption from the competitive bid requirements with Morris & Dickson Co., LLC in the amount of $350,000 for 340B Pharmaceuticals for Public Health Services for the period of January 29, 2026 - January 28, 2027.
end

Background and Discussion:

Harris County Public Health (HCPH) is seeking approval to execute a pharmaceutical supply and distribution agreement with Morris & Dickson Co., LLC to procure brand and generic medications for use across its clinical programs. Morris & Dickson Co., LLC participates in the federal 340B Drug Pricing Program, allowing HCPH to purchase eligible medications at reduced pricing. This approach results in cost savings while ensuring access to medications on both formulary and non-formulary lists. The contract supports the ongoing need for medications used in the treatment, diagnosis, and prevention of disease and allows HCPH to leverage 340B pricing while also utilizing general funds, special revenue, and state and federal grant funding sources as appropriate.

Expected Impact:

Execution of this contract will allow HCPH to continue procuring medications at reduced cost through the 340B program, resulting in more efficient use of funds. It will ensure a reliable supp...

Click here for full text